glp 1 interactions with other drugs Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition GLP-1 Drug Interactions and Telehealth

Discover how GLP-1 and GLP-1/GIP therapies (semaglutide and tirzepatide) influence body composition

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication

What is it and what are the pros and cons?